AGO2	Argonaute 2
AJCC	American Joint Committee on Cancer
BRAF	v-Raf murine sarcoma viral oncogene homolog B
CAFs	Cancer-associated fibroblasts
CDKN2A	Cyclin-dependent kinase inhibitor 2A
CNV	Copy number variations
CSF	Cerebrospinal fluid
CSPG4	Chondroitin sulfate peptidoglycan 4
CTCs	Circulating tumor cells
CTLA-4	Cyto-toxic T-lymphocyteassociated antigen 4
ctmiRNAs	Circulating tumor microRNAs
ddPCR	Droplet digital PCR
DNAm	DNA methilation
EPCAM	Epithelial cell adhesion molecule
EPISTOP	EPithelialImmunoSPOT
EV	Extracellular vesicles
FGFR3	Fibroblast growth factor receptor 3
HNSCC	Head and neck squamous cell carcinoma
HMW-MAA	High-molecular-weight melanoma-associated antibody
ICIs	Immune checkpoint inhibitors
IL-6 and IL-8	Interleukins 6 and 8
KIT	Receptor tyrosin kinase
LB	Liquid biopsy
LOH	Loss of heterozygosity
MAPK	Mitogen-activated protein kinase
MIA	Melanoma inhibitory activity
ML	Circulating tumor DNA
MSI	Microsatellite instability
NF1	Neurofibromin1
NGS	New generation sequencing
NRAS	Neuroblastoma RAS Viral Oncogene Homolog
OS	Overall survival
PD	Progression of disease
PD-1	Programmed cell death protein 1
pEV-miRNAs	EVs-associated miRNAs
PFS	Progression-free survival
PI3K	PhosphatidylInhositol3-kinase
PTEN	Phosphatase and tensin homolog deleted on chromosome 10
qRT-PCR	Real-time quantitative reverse transcription polymerase chain reaction
RFS	Relapse-free survival
SEC	Size-exclusion chromatography
TERT	Telomerase reverse transcriptase
TFPI2	Tissue Factor Pathway Inhibitor 2
TNM	Metastasis system
TYRP2	Tyrosinase-related protein 2